Washington University in St. Louis/ Siteman Cancer Center
Welcome,         Profile    Billing    Logout  
 5 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aft, Rebecca
PROMISE, NCT02694809: The Study: Duavee in Women With DCIS

Completed
2
142
US
Conjugated Estrogens/Bazedoxifene, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, placebo therapy, PLCB, sham therapy, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Northwestern University, National Cancer Institute (NCI), Pfizer, University of Chicago - Department for Cancer Research, University of California, San Francisco
Ductal Breast Carcinoma In Situ, Postmenopausal
06/24
06/24
NCT05545150: Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

Recruiting
2
120
US
Intraoperative Imaging, Lumpectomy, Lumpectomy of Breast, Partial Mastectomy
Northwestern University, National Cancer Institute (NCI)
Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Prognostic Stage 0 Breast Cancer AJCC v8
07/24
07/24
NCT02476786: Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Recruiting
2
50
US
FACT-B, Goserelin, Goserelin acetate, Zoladex, Anastrozole, Arimidex®, Exemestane, Aromasin®, Fulvestrant, Faslodex®, Tamoxifen, Nolvadex®, Archived tissue collection
Washington University School of Medicine, Genomic Health®, Inc.
Breast Cancer, Cancer of Breast, Breast Neoplasms, Cancer of the Breast
01/26
07/31
NCT04331067: Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Active, not recruiting
1/2
15
US
Paclitaxel, Taxol, Carboplatin, Paraplatin, Nivolumab, Opdivo, BMS-936558, Cabiralizumab, BMS-986227, Tumor biopsy, Bone marrow, Blood draw
Washington University School of Medicine, Bristol-Myers Squibb
Triple Negative Breast Cancer
03/23
05/26
NCT02204098: Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

Active, not recruiting
1
27
US
Mammaglobin-A DNA Vaccine, Optional biopsy
Washington University School of Medicine, Rising Tide Foundation, United States Department of Defense
Breast Cancer, Breast Carcinoma, Malignant Neoplasm of Breast
04/22
08/28
NCT06300411: SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery

Recruiting
1
24
US
SRG-514
SURGE Therapeutics
Breast Cancer
09/25
09/25
NCT00353483: Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

Recruiting
N/A
300
US
Peripheral blood draw, Breast tissue collection, Bone marrow biopsy
Washington University School of Medicine
Breast Neoplasms
08/25
08/25
NCT05720039: Robotic vs. Open NSM for Early Stage Breast Cancer

Recruiting
N/A
204
US
Robotic NSM, RNSM, SP NSM, Open NSM
Intuitive Surgical
Breast Cancer Female, Breast Cancer, Breast Cancer, Early-Onset, Breast Disease, Breast
12/25
12/30
COMET, NCT02926911: Comparing an Operation to Monitoring, With or Without Endocrine Therapy () Trial For Low Risk DCIS

Active, not recruiting
N/A
997
US
Surgery, Active Monitoring
Alliance Foundation Trials, LLC., Patient-Centered Outcomes Research Institute, Duke University, Dana-Farber Cancer Institute, M.D. Anderson Cancer Center, New York University, Washington University School of Medicine
DCIS, Ductal Carcinoma in Situ
07/28
07/28

Download Options